Client Result

IVDR Diagnostics Strategy

Project Overview

A top-10 diagnostics company wanted to gauge laboratory preparedness and reactions to the impending implementation of IVDR, and how that would impact portfolio strategy

DeciBio Approach

Primary Research

  • Conducted 31 in-depth interviews with stakeholders across biopharma, academia, clinical labs, and commercial reference labs to understand perspectives on IVDR
  • Assessed trends with respect to current and expected use of NGS testing of various types and panel sizes thoguhout Europe, and how IVDR would impact that

‍

At a glance
31
Interviews
7
Technologies Assessed
9
Countries
Outcomes

A deliverable presented to the client team dived into:

  • Quantified perspectives on IVDR rollout (e.g., familiarity and expectations)
  • Stakeholder technology utilization by type
  • Stakeholder expectations for vendor engagement
  • Key pain points and unmet needs
  • Notified body concentration by geography
  • Expected pathway for IVDR rollout and adoption behavior

The client leveraged these findings to inform which new diagnostic assays to develop for the European market and ancillary capabilities to invest in to service the transitioning European market

Timeline

5 weeks

Geographic Scope

Europe

Industry

Clinical Diagnostics

capabilities

Voice-Of-Customer Research

Biomarker and Diagnostic Strategy

Related Client Results
Clinical Diagnostics
Genetic Testing Lab Target Assessment
A large pharmaceutical company asked DeciBio to help it identify and evaluate clinical genetic testing labs for potential partnership or acquisition
Target Identification
Clinical Diagnostics
MRD Monitoring Market Assessment and Strategy
A diagnostics player wanted to determine which indications and use cases to target and develop a product road map for its planned MRD offering
Biomarker and Diagnostic Strategy
Go-to-Market Strategy
Clinical Diagnostics
Early Cancer Detection Competitor Landscape Monitoring
A top diagnostics player wanted to monitor the commercial, clinical, research, and corporate activities in the public domain for three of the key players in the cancer early detection market.
Competitive Analysis
Clinical Diagnostics
Oncology Diagnostics Landscape Assessment and Model
DeciBio performed a global voice-of-customer (VOC) research campaign with oncologists and pathologists to understand the current adoption and expected trends for NGS kits in oncology diagnostics in the U.S., EU, and APAC.
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Precision Medicine. Precision Insights.
© DeciBio 2022. All rights reserved.
Privacy | Terms & Conditions